Literature DB >> 25533212

Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period.

Timothy R Smith1, Allan D Nanney2, Rishi R Lall2, Randall B Graham2, Jamal McClendon2, Rohan R Lall2, Joseph G Adel2, Anaadriana Zakarija3, David J Cote4, James P Chandler2.   

Abstract

Patients who undergo craniotomy for brain neoplasms have a high risk of developing venous thromboembolism (VTE), including deep vein thromboses (DVT) and pulmonary emboli (PE). The reasons for this correlation are not fully understood. This retrospective, single-center review aimed to determine the risk factors for VTE in patients who underwent neurosurgical resection of brain tumors at Northwestern University from 1999 to 2010. Our cohort included 1148 patients, 158 (13.7%) of whom were diagnosed with DVT and 38 (3.3%) of whom were diagnosed with PE. A variety of clinical factors were studied to determine predictors of VTE, including sex, ethnicity, medical co-morbidities, surgical positioning, length of hospital stay, tumor location, and tumor histology. Use of post-operative anticoagulants and hemorrhagic complications were also investigated. A prior history of VTE was found to be highly predictive of post-operative DVT (odds ratio [OR]=7.6, p=0.01), as was the patient's sex (OR=14.2, p<0.001), ethnicity (OR=0.5, p=0.04), post-operative intensive care unit days (OR=0.2, p=0.003), and tumor histology (OR=-0.16, p=0.01). Contrary to reports in the literature, the data collected did not indicate that the administration of post-operative medical prophylaxis for VTE was significant in preventing their formation (OR=-0.14, p=0.76). Hemorrhagic complications were low (2.2%) and resultant neurologic deficit was lower still (0.7%). The study indicates that patients with high-grade primary brain tumors and metastatic lesions should receive aggressive preventative measures in the post-operative period.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain tumor; Deep vein thrombosis; Neurosurgery; Pulmonary embolism; Venous thromboembolism

Mesh:

Substances:

Year:  2014        PMID: 25533212     DOI: 10.1016/j.jocn.2014.10.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  13 in total

1.  The impact of co-morbidity on the disease burden of VTE.

Authors:  Sonja Kroep; Ling-Hsiang Chuang; Alexander Cohen; Pearl Gumbs; Ben van Hout; Manuel Monreal; Stefan N Willich; Anselm Gitt; Rupert Bauersachs; Giancarlo Agnelli
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

2.  Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Arati Patel; Li Ding; Arun P Amar; Steven L Giannotta; William J Mack; Frank Attenello
Journal:  World Neurosurg       Date:  2018-11-20       Impact factor: 2.104

Review 3.  Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.

Authors:  Nasser Alshehri; David J Cote; M Maher Hulou; Ahmad Alghamdi; Ali Alshahrani; Rania A Mekary; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-09-03       Impact factor: 4.130

Review 4.  Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.

Authors:  Lorenzo Rinaldo; Desmond A Brown; Adip G Bhargav; Aaron E Rusheen; Ryan M Naylor; Hannah E Gilder; Dileep D Monie; Stephanie J Youssef; Ian F Parney
Journal:  J Neurosurg       Date:  2019-01-04       Impact factor: 5.115

5.  Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Authors:  Aditya V Karhade; Luis Fandino; Saksham Gupta; David J Cote; Julian B Iorgulescu; Marike L Broekman; Linda S Aglio; Ian F Dunn; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

6.  Periprostatic venous thrombosis.

Authors:  Eduardo Paulino; Pedro Lobo Alcântara Neves; Luiz Otávio Savassi Rocha
Journal:  Autops Case Rep       Date:  2016-09-30

7.  Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.

Authors:  Joeky T Senders; Nicole H Goldhaber; David J Cote; Ivo S Muskens; Hassan Y Dawood; Filip Y F L De Vos; William B Gormley; Timothy R Smith; Marike L D Broekman
Journal:  J Neurooncol       Date:  2017-10-16       Impact factor: 4.130

8.  A Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy.

Authors:  Eric C Leuthardt; Jeff Voigt; Albert H Kim; Pete Sylvester
Journal:  Pharmacoecon Open       Date:  2017-03

9.  Incidence of Deep Vein Thrombosis in Neurointensive Care Unit Patients-Does Prophylaxis Modality Make Any Difference?

Authors:  Shailaja S Behera; Mathangi Krishnakumar; Radhakrishnan Muthuchellappan; Mariamma Philip
Journal:  Indian J Crit Care Med       Date:  2019-01

Review 10.  A clinical care pathway to improve the acute care of patients with glioma.

Authors:  Natalie B V Riblet; Evelyn M Schlosser; Jennifer A Snide; Lara Ronan; Katherine Thorley; Melissa Davis; Jennifer Hong; Linda P Mason; Tobi J Cooney; Lanelle Jalowiec; Nancy L Kennedy; Sabrina Richie; David Nalepinski; Camilo E Fadul
Journal:  Neurooncol Pract       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.